Monitoring for postnatal hearing loss using risk factors: A systematic literature review

Ear and Hearing

Volumn 33, Issue 6, 2012, Pages 745-756

  Beswick, Rachael ^a,b   Driscoll, Carlie ^a   Kei, Joseph ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; FEMALE; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; INFANT; MALE; NEWBORN; NEWBORN SCREENING; PATIENT REFERRAL; PREGNANCY; PRENATAL EXPOSURE; REGISTER; REVIEW; RISK FACTOR;

EVIDENCE-BASED MEDICINE; FEMALE; HEARING LOSS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REFERRAL AND CONSULTATION; REGISTRIES; RISK FACTORS;

EID: 84871653391     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e31825b1cd9     Document Type: Article

References (80)

1. Ballard, K. (2004). Hearing Screening With Otoacoustic Emissions and Patient Age in a Pediatrician's Practice. Independent Studies and Capstones (Paper 183). St. Louis, MO: Program in Audiology and Communication Sciences, Washington University School of Medicine. Retrieved from http://digitalcommons. wustl.edu/pacs-capstones/183
2. Bamford, J., Fortnum, H., Bristow, K., et al. (2007). Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen. Health Technol Assess, 11, 1-168, iii.
3. Barbi, M., MacKay, W. G., Binda, S., et al. (2008). External quality assessment of cytomegalovirus DNA detection on dried blood spots. BMC Microbiol, 8, 2.
4. Borradori, C., Fawer, C. L., Buclin, T., et al. (1997). Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate, 71, 1-10.
5. Brown, E. D., Chau, J. K., Atashband, S., et al. (2009). A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol, 73, 707-711.
6. Cheung, P. Y., Haluschak, M. M., Finer, N. N., et al. (1996). Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Early Hum Dev, 44, 225-233.
7. Choi, S. Y., Kim, Y. E., Ahn, D. B., et al. (2009). Construction of a DNA chip for screening of genetic hearing loss. Clin Exp Otorhinolaryngol, 2, 44-47.
8. Christensen, M., Thomson, V., Letson, G. W. (2008). Evaluating the reach of universal newborn hearing screening in Colorado. Am J Prev Med, 35, 594-597.
9. Cook, D. J., Greengold, N. L., Ellrodt, A. G., et al. (1997). The relation between systematic reviews and practice guidelines. Ann Intern Med, 127, 210-216.
10. Counsell, C. (1997). Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med, 127, 380-387.
11. Dahle, A. J., Fowler, K. B., Wright, J. D., et al. (2000). Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol, 11, 283-290.
12. de Vries, J. J., Vossen, A. C., Kroes, A. C., et al. (2011). Implementing neonatal screening for congenital cytomegalovirus: Addressing the deafness of policy makers. Rev Med Virol, 21, 54-61.
13. Eiserman, W. D., Hartel, D. M., Shisler, L., et al. (2008). Using otoacoustic emissions to screen for hearing loss in early childhood care settings. Int J Pediatr Otorhinolaryngol, 72, 475-482.
14. Eiserman, W., Shisler, L., Foust, L., et al. (2007). Screening for hearing loss in early childhood programs. Early Child Res Q, 22, 105-117.
15. Fligor, B. J., Neault, M. W., Mullen, C. H., et al. (2005). Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics, 115, 1519-1528.
16. Foulon, I., Naessens, A., Foulon, W., et al. (2008). A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr, 153, 84-88.
17. Fowler, K. B., Dahle, A. J., Boppana, S. B., et al. (1999). Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr, 135, 60-64.
18. Fowler, K. B., McCollister, F. P., Dahle, A. J., et al. (1997). Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr, 130, 624-630.
19. Gardner, P., Oitmaa, E., Messner, A., et al. (2006). Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: A new approach for newborn screening follow-up. Pediatrics, 118, 985-994.
20. Guastini, L., Mora, R., Dellepiane, M., et al. (2010). Evaluation of an automated auditory brainstem response in a multi-stage infant hearing screening. Eur Arch Otorhinolaryngol, 267, 1199-1205.
21. Halloran, D. R., Wall, T. C., Evans, H. H., et al. (2005). Hearing screening at well-child visits. Arch Pediatr Adolesc Med, 159, 949-955.
22. Halpern, J., Hosford-Dunn, H., Malachowski, N. (1987). Four factors that accurately predict hearing loss in "high risk" neonates. Ear Hear, 8, 21-25.
23. Harris, R. P., Helfand, M., Woolf, S. H., et al. Methods Work Group, Third US Preventive Services Task Force. (2001). Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med, 20(3 Suppl), 21-35.
24. Hendricks-Muñoz, K. D., & Walton, J. P. (1988). Hearing loss in infants with persistent fetal circulation. Pediatrics, 81, 650-656.
25. Hicks, T., Fowler, K., Richardson, M., et al. (1993). Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr, 123, 779-782.
26. Hosford-Dunn, H., Johnson, S., Simmons, F. B., et al. (1987). Infant hearing screening: Program implementation and validation. Ear Hear, 8, 12-20.
27. Hutchin, M. E., Gilmer, C., Yarbrough, W. G. (2000). Delayed-onset sensorineural hearing loss in a 3-year-old survivor of persistent pulmonary hypertension of the newborn. Arch Otolaryngol Head Neck Surg, 126, 1014-1017.
28. Hutt, N., & Rhodes, C. (2008). Post-natal hearing loss in universal neonatal hearing screening communities: Current limitations and future directions. J Paediatr Child Health, 44, 87-91.
29. Iwasaki, S., Yamashita, M., Maeda, M., et al. (2007). Audiological outcome of infants with congenital cytomegalovirus infection in a prospective study. Audiol Neurootol, 12, 31-36.
30. Javidnia, H., & Vaccani, J. P. (2009). Progressive sensorineural hearing loss in children with congenital diaphragmatic hernias. J Otolaryngol Head Neck Surg, 38, 29-31.
31. JCIH. (1973). Screening for infant hearing. Retrieved from http://www.jcih.org/posstatemts.htm.
32. JCIH. (2007). Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics, 120, 898-921.
33. Johnson, S. J., Hosford-Dunn, H., Paryani, S., et al. (1986). Prevalence of sensorineural hearing loss in premature and sick term infants with perinatally acquired cytomegalovirus infection. Ear Hear, 7, 325-327.
34. Kawashiro, N., Tsuchihashi, N., Koga, K., et al. (1996). Delayed post-neonatal intensive care unit hearing disturbance. Int J Pediatr Otorhinolaryngol, 34, 35-43.
35. Kennedy, C., Kimm, L., Cafarelli Dees, D., et al. (1998). Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. Wessex Universal Neonatal Hearing Screening Trial Group. Lancet, 352, 1957-1964.
36. Konkle, D. F., & Knightly, C. A. (1993). Delayed-onset hearing loss in respiratory distress syndrome: Case reports. J Am Acad Audiol, 4, 351-354.
37. Korver, A. M., de Vries, J. J., Konings, S., et al. DECIBEL collaborative study group. (2009). DECIBEL study: Congenital cytomegalovirus infection in young children with permanent bilateral hearing impairment in the Netherlands. J Clin Virol, 46 Suppl 4, S27-S31.
38. Lasky, R. E., Wiorek, L., Becker, T. R. (1998). Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high-frequency oscillatory (HFO) therapy. J Am Acad Audiol, 9, 47-58.
39. Law, S., Pollock, N., Letts, L., et al. (1998). Guidelines for Critical Review Form - Quantitative Studies. McMaster University.
40. Leigh, G. (2006). UNHS in Australia: We've come a long way! Audiology Now, 27, 49-51.
41. Leruez-Ville, M., Vauloup-Fellous, C., Couderc, S., et al. (2011). Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots. Clin Infect Dis, 52, 575-581.
42. Mann, T., & Adams, K. (1998). Sensorineural hearing loss in ECMO survivors. Extracorporeal membraneous oxygenation. J Am Acad Audiol, 9, 367-370.
43. Masumoto, K., Nagata, K., Uesugi, T., et al. (2007). Risk factors for sensorineural hearing loss in survivors with severe congenital diaphragmatic hernia. Eur J Pediatr, 166, 607-612.
44. Meade, M. O., & Richardson, W. S. (1997). Selecting and appraising studies for a systematic review. Ann Intern Med, 127, 531-537.
45. Mehl, A. L., & Thomson, V. (2002). The Colorado newborn hearing screening project, 1992-1999: On the threshold of effective population-based universal newborn hearing screening. Pediatrics, 109, E7.
46. Moher, D., Fortin, P., Jadad, A. R., et al. (1996). Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews. Lancet, 347, 363-366.
47. Morton, C. C., & Nance, W. E. (2006). Newborn hearing screening - A silent revolution. N Engl J Med, 354, 2151-2164.
48. Norris, V. W., Arnos, K. S., Hanks, W. D., et al. (2006). Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness. Ear Hear, 27, 732-741.
49. Northern, J. L., & Downs, M. P. (2002). Hearing in Children (5th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
50. Pagarkar, W., Bitner-Glindzicz, M., Knight, J., et al. (2006). Late postnatal onset of hearing loss due to GJB2 mutations. Int J Pediatr Otorhinolaryngol, 70, 1119-1124.
51. Ramsebner, R., Volker, R., Lucas, T., et al. (2007). High incidence of GJB2 mutations during screening of newborns for hearing loss in Austria. Ear Hear, 28, 298-301.
52. Rivera, L. B., Boppana, S. B., Fowler, K. B., et al. (2002). Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics, 110, 762-767.
53. Robertson, C. M., Cheung, P. Y., Haluschak, M. M., et al. (1998). High prevalence of sensorineural hearing loss among survivors of neonatal congenital diaphragmatic hernia. Western Canadian ECMO Follow-up Group. Am J Otol, 19, 730-736.
54. Robertson, C. M., Howarth, T. M., Bork, D. L., et al. (2009). Permanent bilateral sensory and neural hearing loss of children after neonatal intensive care because of extreme prematurity: A thirty-year study. Pediatrics, 123, e797-e807.
55. Robertson, C. M., Tyebkhan, J. M., Hagler, M. E., et al. (2002). Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure. Otol Neurotol, 23, 353-356.
56. Robertson, C. M., Tyebkhan, J. M., Peliowski, A., et al. (2006). Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr, 95, 214-223.
57. Rosenthal, L. S., Fowler, K. B., Boppana, S. B., et al. (2009). Cytomegalovirus shedding and delayed sensorineural hearing loss: Results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J, 28, 515-520.
58. Ross, S. A., Fowler, K. B., Ashrith, G., et al. (2006). Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr, 148, 332-336.
59. Roth, D. A., Hildesheimer, M., Bardenstein, S., et al. (2008). Preauricular skin tags and ear pits are associated with permanent hearing impairment in newborns. Pediatrics, 122, e884-e890.
60. Salamy, A., Eldredge, L., Tooley, W. H. (1989). Neonatal status and hearing loss in high-risk infants. J Pediatr, 114, 847-852.
61. Sataloff, R. T., & Sataloff, J. (2005). Hearing Loss (4th ed.). New York, NY: Taylor & Francis.
62. Schimmenti, L. A., Martinez, A., Fox, M., et al. (2004). Genetic testing as part of the early hearing detection and intervention (EHDI) process. Genet Med, 6, 521-525.
63. Serpanos, Y. C., & Jarmel, F. (2007). Quantitative and qualitative follow-up outcomes from a preschool audiologic screening program: Perspectives over a decade. Am J Audiol, 16, 4-12.
64. Sideris, I., & Glattke, T. J. (2006). A comparison of two methods of hearing screening in the preschool population. J Commun Disord, 39, 391-401.
65. Sweitzer, R. S., Lowry, J. K., Georgeson, K. E., et al. (1997). Hearing loss associated with neonatal ECMO: A clinical investigation. Int J Pediatr Otorhinolaryngol, 41, 339-345.
66. Taylor, B., Wylie, E., Dempster, M., et al. (2007). Systematically retrieving research: A case study evaluating seven databases. Res Social Work Prac, 17, 697-706.
67. Thiringer, K., Kankkunen, A., Lidén, G., et al. (1984). Perinatal risk factors in the aetiology of hearing loss in preschool children. Dev Med Child Neurol, 26, 799-807.
68. Thompson, D. C., McPhillips, H., Davis, R. L., et al. (2001). Universal newborn hearing screening: Summary of evidence. JAMA, 286, 2000-2010.
69. Wang, Q. J., Zhao, Y. L., Rao, S. Q., et al. (2011). Newborn hearing concurrent gene screening can improve care for hearing loss: A study on 14, 913 Chinese newborns. Int J Pediatr Otorhinolaryngol, 75, 535-542.
70. Watkin, P. M., & Baldwin, M. (2011). Identifying deafness in early childhood: Requirements after the newborn hearing screen. Arch Dis Child, 96, 62-66.
71. Watkin, P. M., Baldwin, M., Laoide, S. (1990). Parental suspicion and identification of hearing impairment. Arch Dis Child, 65, 846-850.
72. Watkin, P., Hasan, J., Baldwin, M., et al. (2005). Neonatal hearing screening: Have we taken the right road? Results from a 10-year targeted screen longitudinally followed up in a single district. Audiol Med, 3, 175-184.
73. Weichbold, V., Nekahm-Heis, D., Welzl-Mueller, K. (2006). Universal newborn hearing screening and postnatal hearing loss. Pediatrics, 117, e631-e636.
74. Weichbold, V., Rohrer, M., Winkler, C., et al. (2004). [Hearing screening at nursery schools: Results of an evaluation study]. Wien Klin Wochenschr, 116, 478-483.
75. Williamson, W. D., Demmler, G. J., Percy, A. K., et al. (1992). Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics, 90, 862-866.
76. Winskel, H. (2006). The effects of an early history of otitis media on children's language and literacy skill development. Br J Educ Psychol, 76(Pt 4), 727-744.
77. Yamamoto, A. Y., Mussi-Pinhata, M. M., Marin, L. J., et al. (2006). Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol, 36, 228-230.
78. Yamamoto, A. Y., Mussi-Pinhata, M. M., Pinto, P. C., et al. (2001). Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Methods, 97, 159-164.
79. Yin, L., Bottrell, C., Clarke, N., et al. (2009). Otoacoustic emissions: A valid, efficient first-line hearing screen for preschool children. J Sch Health, 79, 147-152.
80. Yoong, S. Y., & Spencer, N. J. (2008). A data collection system to audit post-newborn hearing surveillance programme: Problems and possibilities. Child Care Health Dev, 34, 648-656.